Literature DB >> 22581334

Adipokine leptin in obesity-related pathology of breast cancer.

Amitabha Ray1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22581334     DOI: 10.1007/s12038-012-9191-9

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


× No keyword cloud information.
  49 in total

1.  The antiproliferative effects of pterostilbene on breast cancer in vitro are via inhibition of constitutive and leptin-induced Janus kinase/signal transducer and activator of transcription activation.

Authors:  Denise McCormack; John Schneider; Debbie McDonald; David McFadden
Journal:  Am J Surg       Date:  2011-09-23       Impact factor: 2.565

Review 2.  Principles of strategic drug delivery to the brain (SDDB): development of anorectic and orexigenic analogs of leptin.

Authors:  W A Banks; A Gertler; G Solomon; L Niv-Spector; M Shpilman; X Yi; E Batrakova; S Vinogradov; A V Kabanov
Journal:  Physiol Behav       Date:  2011-06-06

3.  Leptin and Inflammation.

Authors:  Noriko Iikuni; Queenie Lai Kwan Lam; Liwei Lu; Giuseppe Matarese; Antonio La Cava
Journal:  Curr Immunol Rev       Date:  2008-05-01

Review 4.  Effect of obesity on breast cancer development.

Authors:  M P Cleary; M E Grossmann; A Ray
Journal:  Vet Pathol       Date:  2010-02-01       Impact factor: 2.221

5.  Relationships between hypoxia markers and the leptin system, estrogen receptors in human primary and metastatic breast cancer: effects of preoperative chemotherapy.

Authors:  Mariusz Koda; Luiza Kanczuga-Koda; Mariola Sulkowska; Eva Surmacz; Stanislaw Sulkowski
Journal:  BMC Cancer       Date:  2010-06-22       Impact factor: 4.430

6.  Leptin utilizes Jun N-terminal kinases to stimulate the invasion of MCF-7 breast cancer cells.

Authors:  Vanity McMurtry; Ann-Marie Simeone; René Nieves-Alicea; Ana M Tari
Journal:  Clin Exp Metastasis       Date:  2008-12-27       Impact factor: 5.150

7.  Leptin augments proliferation of breast cancer cells via transactivation of HER2.

Authors:  Daisuke Soma; Joji Kitayama; Hiroharu Yamashita; Hideyo Miyato; Makoto Ishikawa; Hirokazu Nagawa
Journal:  J Surg Res       Date:  2007-11-26       Impact factor: 2.192

8.  Circulating levels of leptin, adiposity and breast cancer risk.

Authors:  M-H Wu; Y-C Chou; W-Y Chou; G-C Hsu; C-H Chu; C-P Yu; J-C Yu; C-A Sun
Journal:  Br J Cancer       Date:  2009-02-24       Impact factor: 7.640

9.  Leptin receptor expression and cell signaling in breast cancer.

Authors:  Krista A Frankenberry; Heath Skinner; Ponnandai Somasundar; David W McFadden; Linda C Vona-Davis
Journal:  Int J Oncol       Date:  2006-04       Impact factor: 5.650

10.  Effects of leptin on human breast cancer cell lines in relationship to estrogen receptor and HER2 status.

Authors:  Amitabha Ray; Katai J Nkhata; Margot P Cleary
Journal:  Int J Oncol       Date:  2007-06       Impact factor: 5.650

View more
  23 in total

1.  Visfatin Exerts Immunotherapeutic Effects in Lipopolysaccharide-Induced Acute Lung Injury in Murine Model.

Authors:  You Luo; Xin-Xin Pang; Abdur Rahman Ansari; Xin-Tong Wu; Hui-Zhen Li; Zhe-Wei Zhang; Hui Song
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

2.  Obesity and Breast Cancer Risk: The Oncogenic Implications of Metabolic Dysregulation.

Authors:  Sandra C Naaman; Sherry Shen; Meltem Zeytinoglu; Neil M Iyengar
Journal:  J Clin Endocrinol Metab       Date:  2022-07-14       Impact factor: 6.134

3.  Obesity, insulin resistance, adipocytokines and breast cancer: New biomarkers and attractive therapeutic targets.

Authors:  Maria Dalamaga
Journal:  World J Exp Med       Date:  2013-08-20

4.  Interplay of adipokines and myokines in cancer pathophysiology: Emerging therapeutic implications.

Authors:  Maria Dalamaga
Journal:  World J Exp Med       Date:  2013-08-20

5.  Interaction between obesity-related genes, FTO and MC4R, associated to an increase of breast cancer risk.

Authors:  Patrícia Amorim da Cunha; Lia Kubelka de Carlos Back; Aline Fernanda Rodrigues Sereia; Clara Kubelka; Maria Cecíia Menks Ribeiro; Bráulio Leal Fernandes; Ilíada Rainha de Souza
Journal:  Mol Biol Rep       Date:  2013-10-04       Impact factor: 2.316

6.  Favorable changes in serum estrogens and other biologic factors after weight loss in breast cancer survivors who are overweight or obese.

Authors:  Cheryl L Rock; Chetna Pande; Shirley W Flatt; Carl Ying; Bilge Pakiz; Barbara A Parker; Kathryn Williams; Wayne A Bardwell; Dennis D Heath; Jeanne F Nichols
Journal:  Clin Breast Cancer       Date:  2013-01-29       Impact factor: 3.225

Review 7.  The potential role of leptin in tumor invasion and metastasis.

Authors:  Amitabha Ray; Margot P Cleary
Journal:  Cytokine Growth Factor Rev       Date:  2017-11-11       Impact factor: 7.638

8.  Reducing breast cancer recurrence with weight loss, a vanguard trial: the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial.

Authors:  Cheryl L Rock; Tim E Byers; Graham A Colditz; Wendy Demark-Wahnefried; Patricia A Ganz; Kathleen Y Wolin; Anthony Elias; Helen Krontiras; Jingxia Liu; Michael Naughton; Bilgé Pakiz; Barbara A Parker; Rebecca L Sedjo; Holly Wyatt
Journal:  Contemp Clin Trials       Date:  2012-12-22       Impact factor: 2.226

9.  The Association between Leptin Level and Breast Cancer: A Meta-Analysis.

Authors:  Jingping Niu; Le Jiang; Weiheng Guo; Liang Shao; Yi Liu; Liqin Wang
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

Review 10.  Leptin, resistin and visfatin: the missing link between endocrine metabolic disorders and immunity.

Authors:  Ebtesam A Al-Suhaimi; Adeeb Shehzad
Journal:  Eur J Med Res       Date:  2013-05-01       Impact factor: 2.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.